Chest wall hernia induced by high intensity focused ultrasound treatment of unresectable massive hepatocellular carcinoma: A case report

Chen,Qi‑Wen; Teng,Wen‑Jing; Chen,Qian

doi:10.3892/ol.2016.4618

Chest wall hernia induced by high intensity focused ultrasound treatment of unresectable massive hepatocellular carcinoma: A case report

Authors:
- Qi‑Wen Chen
- Wen‑Jing Teng
- Qian Chen
View Affiliations

Affiliations: Department of Integrated Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, P.R. China, Cancer Center, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai 200041, P.R. China, Department of Obstetrics of Chongqing Haifu Hospital, Non‑Invasive and Minimally Invasive Therapeutic Research Center for Uterine Benign Diseases of Chongqing, Chongqing 401121, P.R. China
Published online on: May 25, 2016 https://doi.org/10.3892/ol.2016.4618
Pages: 627-630

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

In the present study, a case of unresectable massive hepatocellular carcinoma (HCC) treated with high intensity focused ultrasound (HIFU) alone is reported. Although the treatment induced chest wall hernia, its efficacy in treating the HCC was demonstrated. The medical records of a patient with an unresectable massive tumor that was effectively treated with serial HIFU ablation were retrospectively studied. Chest wall hernia was detected as a complication of the HIFU treatment, which has not been reported thus far in the literature. The patient has survived for 44 months since the first diagnosis in September 2010. Treatment resulted in partial remission of the tumor, pain relief, decreased levels of alpha‑fetoprotein and chest wall hernia, as a complication. Therefore, HIFU may be an effective approach for the treatment of unresectable HCC, although it may occasionally cause complications.

View Figures

View References

1	Flores A and Marrero JA: Emerging trends in hepatocellular carcinoma: Focus on diagnosis and therapeutics. Clin Med Insights Oncol. 8:71–76. 2014.PubMed/NCBI
2	Chang PE, Ong WC, Lui HF and Tan CK: Is theprognosis of young patients with hepatocellular carcinoma poorer than the prognosis of older patients? A comparative analysis of clinical characteristics, prognostic features, and survival outcome. J Gastroenterol. 43:881–888. 2008. View Article : Google Scholar : PubMed/NCBI
3	Rasool M, Rashid S, Arooj M, Ansari SA, Khan KM, Malik A, Naseer MI, Zahid S, Manan A, Asif M, et al: New possibilities in hepatocellular carcinoma treatment. Anticancer Res. 34:1563–1571. 2014.PubMed/NCBI
4	Bruix J and Sherman M: American Association for the Study of Liver Diseases: Management of hepatocellular carcinoma: An update. Hepatology. 53:1020–1022. 2011. View Article : Google Scholar : PubMed/NCBI
5	Rust C and Gores GJ: Locoregional management of hepatocellular carcinoma. Surgical and ablation therapies. Clin Liver Dis. 5:161–173. 2001. View Article : Google Scholar : PubMed/NCBI
6	Brown MR, Farquhar-Smith P, Williams JE, ter Haar G and deSouza NM: The use of high-intensity focused ultrasound as a novel treatment for painful conditions - a description and narrative review of the literature. Br J Anaesth. 115:520–530. 2015. View Article : Google Scholar : PubMed/NCBI
7	Zhang Y, Deng J, Feng J and Wu F: Enhancement of antitumor vaccine in ablated hepatocellular carcinoma by high-intensity focused ultrasound. World J Gastroenterol. 16:3584–3591. 2010. View Article : Google Scholar : PubMed/NCBI
8	Jiang L, Yan L, Wen T, Li B, Zeng Y, Yang J, Wang W, Xu M and Wu H: Comparison of outcomes of hepatic resection and radiofrequency ablation for hepatocellular carcinoma patients with multifocal tumors meeting the Barcelona-Clinic Liver Cancer stage A classification. J Am Coll Surg. 221:951–961. 2015. View Article : Google Scholar : PubMed/NCBI
9	Zhong X, Lim EA, Hershman DL, Moinpour CM, Unger J, Lee SM, Zhong X, Lim EA, Hershman DL, Moinpour CM, et al: ReCAP: Identifying severe adverse event clusters using the National Cancer Institute's Common Terminology Criteria for Adverse Events. J Oncol Pract. 12:245–246. 2016. View Article : Google Scholar : PubMed/NCBI
10	Song T: Recent advances in surgical treatment of hepatocellular carcinoma. Drug Discov Ther. 9:319–330. 2015. View Article : Google Scholar : PubMed/NCBI
11	Hołówko W, Wróblewski T, Wojtaszek M, Grąt M, Kobryń K, Ziarkiewicz-Wróblewska B and Krawczyk M: Transarterial chemoembolization prior to liver transplantation in patients with hepatocellular carcinoma. Ann Transplant. 20:764–768. 2015. View Article : Google Scholar : PubMed/NCBI
12	Miyahara K, Nouso K and Yamamoto K: Chemotherapy for advanced hepatocellular carcinoma in the sorafenib age. World J Gastroenterol. 20:4151–4159. 2014. View Article : Google Scholar : PubMed/NCBI
13	Lee SH, Kim SU, Jang JW, Bae SH, Lee S, Kim BK, Park JY, Kim Do Y, Ahn SH and Han KH: Use of transient elastography to predict de novo recurrence after radiofrequency ablation for hepatocellular carcinoma. Onco Targets Ther. 8:347–356. 2015. View Article : Google Scholar : PubMed/NCBI
14	Ten Eikelder HM, Bošnački D, Elevelt A, Donato K, Di Tullio A, Breuer BJ, van Wijk JH, van Dijk EV, Modena D, Yeo SY and Grüll H: Modelling the temperature evolution of bone under high intensity focused ultrasound. Phys Med Biol. 61:1810–1828. 2016. View Article : Google Scholar : PubMed/NCBI
15	de Greef M, Schubert G, Wijlemans JW, Koskela J, Bartels LW, Moonen CT and Ries M: Intercostal high intensity focused ultrasound for liver ablation: The influence of beam shaping on sonication efficacy and near-field risks. Med Phys. 42:4685–4697. 2015. View Article : Google Scholar : PubMed/NCBI
16	Li CC, Wang YQ, Li YP and Li XL: High-intensity focused ultrasound for treatment of pancreatic cancer: A systematic review. J Evid Based Med. 7:270–281. 2014. View Article : Google Scholar : PubMed/NCBI
17	Wu F, Chen WZ, Bai J, Zou JZ, Wang ZL, Zhu H and Wang ZB: Pathological changes in human malignant carcinoma treated with high-intensity focused ultrasound. Ultrasound Med Biol. 27:1099–1106. 2001. View Article : Google Scholar : PubMed/NCBI
18	Blana A, Walter B, Rogenhofer S and Wieland WF: High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience. Urology. 63:297–300. 2004. View Article : Google Scholar : PubMed/NCBI
19	Wang W, Wang Y, Wang T, Wang J, Wang L and Tang J: Safety and efficacy of US-guided high-intensity focused ultrasound for treatment of submucosal fibroids. Eur Radiol. 22:2553–2558. 2012. View Article : Google Scholar : PubMed/NCBI